• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吉西他滨联合替吉奥化疗后行胆囊癌合并肝脏侵犯和肝转移的根治性切除术:1 例报告。

Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.

机构信息

Department of Surgery, Saga University Faculty of Medicine, Nabeshima 5-1-1, Saga, 849-8501, Japan.

出版信息

World J Surg Oncol. 2014 Nov 4;12:326. doi: 10.1186/1477-7819-12-326.

DOI:10.1186/1477-7819-12-326
PMID:25367161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4226861/
Abstract

A 62-year-old woman diagnosed with gallbladder cancer exhibiting broad liver invasion and metastasis to Couinaud's hepatic segments 4 and 8 (S4 and S8) consulted her regular doctor. Owing to the presence of liver metastases, she received treatment with gemcitabine plus S-1. After four cycles of chemotherapy, the size of the main lesion dramatically decreased and the two liver metastases disappeared. After six cycles of chemotherapy, the patient was referred to our hospital for surgical treatment. Upon admission, there was no evidence of any distant metastasis, based on a detailed radiological examination. Therefore, we performed cholecystectomy and central bisegmentectomy of the liver after obtaining the patient's informed consent. Pathological examination demonstrated viable cancer cells with granuloma formation and calcification in the gallbladder, as well as regenerative changes without viable cancer cells in S4 and S8 of the liver. Gemcitabine plus S-1 was again administered as postoperative adjuvant chemotherapy. One and a half years after the surgery, there were no signs of recurrence. In patients selected according to their response to chemotherapy, surgical treatment might therefore be effective against gallbladder cancer with metastasis.

摘要

一位 62 岁女性被诊断患有胆囊癌,广泛侵犯肝脏并转移至 Couinaud 肝段 S4 和 S8(S4 和 S8),她咨询了她的主治医生。由于存在肝转移,她接受了吉西他滨加 S-1 的治疗。经过四个周期的化疗,主要病变显著缩小,两个肝转移灶消失。六个周期的化疗后,患者被转介到我们医院接受手术治疗。入院时,根据详细的影像学检查,没有任何远处转移的证据。因此,在获得患者知情同意后,我们进行了胆囊切除术和肝中叶切除术。病理检查显示胆囊内有活癌细胞和肉芽肿形成及钙化,S4 和 S8 肝内有再生改变而无活癌细胞。术后再次给予吉西他滨加 S-1 辅助化疗。手术后 1 年半,无复发迹象。对于根据化疗反应选择的患者,手术治疗可能对转移性胆囊癌有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56f/4226861/1d2d3c4621b7/12957_2014_1794_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56f/4226861/1253f014c3a1/12957_2014_1794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56f/4226861/84223b5ae777/12957_2014_1794_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56f/4226861/1d2d3c4621b7/12957_2014_1794_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56f/4226861/1253f014c3a1/12957_2014_1794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56f/4226861/84223b5ae777/12957_2014_1794_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56f/4226861/1d2d3c4621b7/12957_2014_1794_Fig3_HTML.jpg

相似文献

1
Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.吉西他滨联合替吉奥化疗后行胆囊癌合并肝脏侵犯和肝转移的根治性切除术:1 例报告。
World J Surg Oncol. 2014 Nov 4;12:326. doi: 10.1186/1477-7819-12-326.
2
Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine.吉西他滨化疗后肝转移胆囊癌的切除术
J Hepatobiliary Pancreat Surg. 2008;15(6):655-8. doi: 10.1007/s00534-007-1311-9. Epub 2008 Nov 7.
3
[A Case of Locally Advanced Gallbladder Cancer That Developed Early Multiple Liver Metastasis after Curative Resection, and Achieved Long-TermPartial Remission Using S-1 and Gemcitabine].[1例局部进展期胆囊癌根治性切除术后早期发生多发肝转移,采用S-1和吉西他滨实现长期部分缓解的病例]
Gan To Kagaku Ryoho. 2016 Nov;43(12):2086-2088.
4
[Resection of Initially Unresectable Gallbladder Cancer with Multiple Liver Metastases after Chemotherapy with Gemcitabine plus Cisplatin].[吉西他滨联合顺铂化疗后对初始不可切除的伴多发肝转移胆囊癌进行切除]
Gan To Kagaku Ryoho. 2015 Nov;42(12):1500-2.
5
[Curative resection of gallbladder cancer with simultaneous liver metastasis].[胆囊癌伴同时性肝转移的根治性切除]
Gan To Kagaku Ryoho. 2011 Nov;38(12):2433-5.
6
[A Case of Radical Hepatectomy in a Patient with Recurrent Liver Metastasis of Gallbladder Cancer after Successful Chemotherapy with GC+Durvalumab].[1例胆囊癌肝转移复发患者在接受GC+度伐利尤单抗化疗成功后行根治性肝切除术]
Gan To Kagaku Ryoho. 2024 Aug;51(8):843-845.
7
[Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy].对吉西他滨联合S-1化疗显示完全缓解的晚期胆囊癌
Nihon Shokakibyo Gakkai Zasshi. 2011 Jul;108(7):1263-70.
8
[A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder].[一例晚期胃癌伴肝和胆囊转移行根治性切除术后发生的转移性结肠癌]
Gan To Kagaku Ryoho. 2014 Nov;41(12):2422-4.
9
[Recurrent gallbladder carcinoma treated with combination chemotherapy with gemcitabine, CPT-11 and S-1--a successful case with metastatic tumors replaced by marked calcification].[吉西他滨、CPT-11和S-1联合化疗治疗复发性胆囊癌——转移性肿瘤被显著钙化替代的成功病例]
Gan To Kagaku Ryoho. 2008 May;35(5):837-9.
10
[Surgical Resection after Chemotherapy for Ampullary Carcinoma with Synchronous Liver Metastasis--Report of a Case].[同步肝转移壶腹癌化疗后手术切除——1例报告]
Gan To Kagaku Ryoho. 2015 Nov;42(12):1758-60.

引用本文的文献

1
Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway.外泌体长链非编码 RNA TRPM2-AS 通过与 PABPC1 相互作用激活 NOTCH1 信号通路促进胆囊癌血管生成。
Mol Cancer. 2024 Mar 27;23(1):65. doi: 10.1186/s12943-024-01979-z.
2
Effects of surgery on survival of elderly patients with gallbladder cancer: A propensity score matching analysis of the SEER database.手术对老年胆囊癌患者生存的影响:基于监测、流行病学与最终结果(SEER)数据库的倾向评分匹配分析
Front Oncol. 2023 Mar 1;13:1083618. doi: 10.3389/fonc.2023.1083618. eCollection 2023.
3

本文引用的文献

1
Current status of chemotherapy for the treatment of advanced biliary tract cancer.晚期胆道癌化疗治疗的现状。
Korean J Intern Med. 2013 Sep;28(5):515-24. doi: 10.3904/kjim.2013.28.5.515. Epub 2013 Aug 14.
2
Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).吉西他滨联合 S-1 对比 S-1 治疗晚期胆道癌的随机 II 期研究:日本临床肿瘤学组研究(JCOG0805)
Cancer Sci. 2013 Sep;104(9):1211-6. doi: 10.1111/cas.12218. Epub 2013 Jul 25.
3
A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer.
KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer.
KIF11 通过 ERBB2/PI3K/AKT 信号通路促进胆囊癌细胞增殖。
Int J Biol Sci. 2021 Jan 1;17(2):514-526. doi: 10.7150/ijbs.54074. eCollection 2021.
4
Salvage Surgery for Metastatic Gall Bladder Cancer with Vanishing Liver Metastasis Following Palliative 5-Fluorouracil Metronomic Chemotherapy.姑息性5-氟尿嘧啶节拍化疗后肝转移灶消失的转移性胆囊癌挽救性手术
J Clin Diagn Res. 2017 May;11(5):XD03-XD05. doi: 10.7860/JCDR/2017/26460.9938. Epub 2017 May 1.
S-1 治疗吉西他滨耐药性胆道癌的多中心 II 期研究。
Cancer Chemother Pharmacol. 2013 May;71(5):1141-6. doi: 10.1007/s00280-013-2106-0. Epub 2013 Mar 24.
4
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study.二线化疗在晚期胆道癌中的可行性和获益:一项大型回顾性研究。
Eur J Cancer. 2013 Jan;49(2):329-35. doi: 10.1016/j.ejca.2012.08.003. Epub 2012 Sep 1.
5
Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer.输注型氟尿嘧啶、多柔比星和丝裂霉素 C(iFAM)化疗治疗难治性晚期胆道癌的疗效及预后因素分析。
Oncology. 2012;83(2):57-66. doi: 10.1159/000338795. Epub 2012 Jun 29.
6
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: a multicentre, multinational study.舒尼替尼二线治疗晚期胆道癌的 II 期研究:一项多中心、多国研究。
Eur J Cancer. 2012 Jan;48(2):196-201. doi: 10.1016/j.ejca.2011.11.017. Epub 2011 Dec 14.
7
Imatinib mesylate for palliative second-line treatment of advanced biliary tract cancer: a bicentric phase II study.甲磺酸伊马替尼用于晚期胆管癌的姑息性二线治疗:一项双中心II期研究。
Onkologie. 2011;34(8-9):469-70. doi: 10.1159/000331065. Epub 2011 Aug 22.
8
[Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy].对吉西他滨联合S-1化疗显示完全缓解的晚期胆囊癌
Nihon Shokakibyo Gakkai Zasshi. 2011 Jul;108(7):1263-70.
9
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine.多中心 II 期研究:S-1 单药治疗吉西他滨耐药的晚期胆道癌。
Invest New Drugs. 2012 Apr;30(2):708-13. doi: 10.1007/s10637-010-9553-9. Epub 2010 Oct 6.
10
[A case of gallbladder cancer which completely responded to gemcitabine].[一例对吉西他滨完全缓解的胆囊癌病例]
Gan To Kagaku Ryoho. 2010 Sep;37(9):1771-3.